OKTA vs PSTV · P/E 84, rev $1.57B vs P/E 0.2, rev $5.8M
Okta Inc (OKTA) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the OKTA and PSTV stock pages for the full models.
Not investment advice.